US Markets
Home›US Markets›Equities›AtriCure director sells $905,000 of shares at $38.80 e…
AtriCure director sells $905,000 of shares at $38.80 each
The director sold 23,325 shares on August 5, trimming her direct holdings by 14% to 22,809 shares.
AtriCure, Inc. (NASDAQ:ATRC) said a director, Karen Prange, sold 23,325 shares of common stock on August 5, according to an SEC Form 4 filing highlighted by The Motley Fool.
The sale was executed at a weighted average price of $38.80 per share, while the stock closed at $39.34 on August 5, making the transaction price lower than that close.
The Form 4 indicates Prange reduced her direct equity by 14%, leaving her with 22,809 shares after the open-market sale.
As of the August 6 market close, AtriCure had a $2.0 billion market capitalization and reported trailing twelve-month revenue of $569.6 million, with the company selling specialized medical devices used in cardiac surgery and arrhythmia treatment.
Latest closeNasdaq Comp. 27,193.34 ▼1.2%